Regeneron Pharmaceuticals, Inc.
REGN
$891.96
-$0.52-0.06%
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | -3.13% | -23.40% | 13.65% | -15.99% | -46.29% |
| Total Depreciation and Amortization | 12.89% | 13.82% | 38.58% | 33.92% | 34.36% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -398.53% | 272.37% | -92.32% | -9.23% | -90.41% |
| Change in Net Operating Assets | -116.07% | 71.18% | 89.59% | -70.74% | 207.48% |
| Cash from Operations | -36.64% | 77.18% | 81.15% | -34.93% | -27.51% |
| Capital Expenditure | -65.18% | -23.51% | 26.43% | -25.67% | 1.74% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 111.08% | -180.41% | -7,479.67% | 96.32% | 8.20% |
| Cash from Investing | 96.44% | -358.09% | -476.69% | 86.18% | 7.70% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -19.22% | -15.67% | -70.44% | -6.98% | -31.34% |
| Repurchase of Common Stock | -20.46% | 35.23% | -72.81% | -76.78% | 57.21% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -80.17% | 43.82% | -507.52% | -598.45% | 72.69% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 249.87% | 118.81% | -4,106.28% | 75.54% | 29.52% |
